Welcome to our dedicated page for Mccormick & Co SEC filings (Ticker: MKC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
McCormick & Company, Incorporated filings document the regulatory disclosures of a Maryland operating company with NYSE-listed non-voting common stock under the symbol MKC. Recent 8-K reports cover operating and financial results, material definitive agreements, capital-structure disclosures and exhibits tied to the company's flavor business.
The filing record also includes shareholder voting results from the annual meeting, board and auditor matters, advisory compensation votes, governance changes involving accounting oversight, and registered share-plan disclosures connected to the company's Investor Services Plan. These filings describe formal corporate actions, security structure and governance matters alongside McCormick's Consumer and Flavor Solutions reporting.
McCormick & Company, Incorporated entered into a Term Loan Agreement providing the ability to borrow up to $2.0 billion at the closing of its pending combination with Unilever’s foods business. The proceeds are intended to fund part of the cash consideration and related transaction costs.
The term loan facility will mature three years after the merger closing and carries a floating interest rate based on McCormick’s choice of Term SOFR plus a margin of 0.750% to 1.500% or Base Rate plus a margin of 0.000% to 0.500%, depending on credit ratings. McCormick must maintain a Consolidated EBITDA to Interest Expense ratio of at least 3.75:1.00.
From July 29, 2026 until the earlier of commitment termination or closing, McCormick will pay a 0.10% per annum ticking fee on the undrawn commitments. Effective April 28, 2026, the company also terminated $2.0 billion of commitments under a previously arranged $15.7 billion bridge facility, anticipating use of this new term loan instead.
McCormick & Co Inc Schedule 13G: Vanguard Capital Management reports beneficial ownership of 19,099,707 shares of Common Stock, representing 7.53% of the class as of 03/31/2026. The filing lists sole voting power of 2,587,495 shares and sole dispositive power of 19,099,707 shares. The report is signed by Ashley Grim on 04/30/2026 and states holdings include securities held for Vanguard funds and managed accounts.
McCormick & Co., Inc. ownership filing reports that Vanguard Portfolio Management beneficially owned 13,895,266 shares of Common Stock, representing 5.47% of the class as of 03/31/2026. The filing states Vanguard has sole dispositive power over 13,895,266 shares and sole voting power for 30,650 shares. The disclosure clarifies holdings include securities held for Vanguard funds and client accounts managed by affiliated business divisions.
Piper Sarah reported acquisition or exercise transactions in this Form 4 filing.
MCCORMICK & CO INC Chief Human Relations Officer Sarah Piper reported a routine compensation-related award. She received 7.882 shares of Phantom Stock at $51.9800 per unit, each representing the right to receive one share of Common Stock - Voting under the Non Qualified Retirement Savings Plan.
Following this award, her indirect holdings in Phantom Stock total 4,398.086 units, while her directly owned Common Stock - Voting holdings stand at 9,017.040 shares. These entries reflect plan-based accruals rather than open-market buying or selling.
Foley Brendan M reported acquisition or exercise transactions in this Form 4 filing.
MCCORMICK & CO INC Chairman, President & CEO Brendan M. Foley reported a compensation-related award of phantom stock rather than an open-market trade. He received 48.225 units of Phantom Stock at $51.98 per unit under a Non-Qualified Retirement Savings Plan, each unit representing one share of Common Stock - Voting.
After this award, Foley’s plan account holds 13,779.888 phantom stock units linked to Common Stock - Voting. Separately, his direct holdings total 130,056.016 shares of Common Stock - Voting and 1,383.460 shares of Common Stock - Non Voting. The filing also includes two entries that simply restate his direct share holdings without indicating new purchases or sales.
McCormick & Company, Incorporated has reassigned senior leadership to support its proposed combination with the foods business of Unilever PLC. Andrew Foust, previously President Americas, has been appointed Chief Integration Officer to lead integration of the transaction while remaining an executive officer.
Patrick Davis has been named Interim President Americas while Foust focuses on integration; the company currently expects Foust to return to his President Americas role after integration is completed. The document also explains that investors will receive detailed information about the proposed transaction through future SEC filings, including a Form S-4 proxy statement/prospectus and a Form 10 information statement for the Unilever Foods spin-off, and clarifies that this communication is not an offer to buy or sell securities.
McCormick & Co. Chief Growth & Marketing Officer Tabata Lorena Gomez Sades filed an initial ownership report outlining her equity interests in the company. She directly holds 6,143 shares of Common Stock – Voting.
She also holds an option on 7,996 shares of common stock with an exercise price of $76.03 per share, expiring on March 27, 2034. In addition, she has several blocks of Restricted Stock Units tied to common stock: 688, 3,124, and 8,656 underlying shares, each vesting in thirds over three years beginning on February 15, 2025, 2026, and 2027, respectively.
McCormick & Company disclosed details in a Barclays fireside chat about its announced acquisition of Unilever Foods, framing the deal as a strategic move to create a global pure-play flavor company. Management reiterated a clear integration plan, $600 million of run-rate cost synergies, $100 million earmarked for reinvestment, and an expected close in mid-2027. Pro forma 2025 combined starting metrics cited $20 billion revenue and ~21% operating margin. Management expects mid- to high-single-digit adjusted EPS accretion in year one and mid- to high-teens by year three, with EVA positive in four to five years and deleveraging to ~3x within two years.
McCormick & Company disclosed details in a Barclays fireside chat about its announced acquisition of Unilever Foods, framing the deal as a strategic move to create a global pure-play flavor company. Management reiterated a clear integration plan, $600 million of run-rate cost synergies, $100 million earmarked for reinvestment, and an expected close in mid-2027. Pro forma 2025 combined starting metrics cited $20 billion revenue and ~21% operating margin. Management expects mid- to high-single-digit adjusted EPS accretion in year one and mid- to high-teens by year three, with EVA positive in four to five years and deleveraging to ~3x within two years.
McCormick & Co. director Gavin Hattersley increased his personal stake by buying shares in the open market. On April 10, 2026, he purchased 2,000 shares of McCormick non-voting common stock at $52.98 per share in an open-market transaction. Following this purchase, he directly holds 2,906 non-voting shares and 406 voting shares of McCormick common stock.
MCCORMICK & CO INC vice president and controller Julie Giese has filed an initial statement of beneficial ownership. She directly holds 725 shares of Common Stock – Voting. She also holds Restricted Stock Units tied to 322, 1,071 and 1,955 underlying common shares at an exercise price of $0.00 per share.
The RSUs vest in thirds over three-year periods. One grant begins vesting on March 15, 2025, another on February 15, 2026, and a third on February 15, 2027, providing a staggered schedule of future share delivery if employment and plan conditions are met.